Open AccessAmantadine extended release capsules (GOCOVRI®) in Parkinson’s disease: a profile of its use in the USA
Author(s) -
Zaina T. Al-Salama
Publication year - 2022
Publication title -
drugs and therapy perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.127
H-Index - 8
eISSN - 1179-1977
pISSN - 1172-0360
DOI - 10.1007/s40267-022-00912-y
Subject(s) - amantadine , dyskinesia , medicine , bedtime , adverse effect , placebo , levodopa , parkinson's disease , anesthesia , pharmacology , disease , alternative medicine , pathology